Kiniksa Pharmaceuticals, Ltd. Gains 30.39%
Tue, Jul 25, 2023 at 07:27 PM
Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ) rocketted at $19.48, representing a gain of 30.4%. On Tue, Jul 25, 2023, KNSA:NASDAQ hit a New 2-Week High of $19.48. The stock got featured on our News Catalysts scanner on Tue, Jul 25, 2023 at 07:48 AM in the 'EARNINGS' category. From Tue, Jul 11, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days
About Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ)
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
Top 10 Gainers:
- Aurora Acquisition Corp. (AURC:NASDAQ), 220.86%
- Inpixon (INPX:NASDAQ), 89.49%
- Electra Battery Materials Corporation (ELBM:NASDAQ), 70.73%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Bullfrog AI Holdings Inc. (BFRG:NASDAQ), 44.22%
- Yoshiharu Global Co. (YOSH:NASDAQ), 41.23%
- Signature Bank (SBNY:NASDAQ), 34%
- Galecto Inc. (GLTO:NASDAQ), 31.47%
- Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ), 30.39%
- Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 25.48%